Morgan Stanley Discount Zert STX .../ DE000ME7KYC9 /
28/05/2024 11:05:46 | Diferencia-0.02 | Bid13:48:09 | Ask13:48:09 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
79.99EUR | -0.02% | 79.79 Volumen de oferta: 75 |
80.27 Tamaño/ Volumen/ Formato de Ask: 75 |
Seagate Technology H... | - USD | 27/09/2024 | Call |
GlobeNewswire
14:01
ParaZero Received a Purchase Order for its Advanced Safety Systems for UAE-based Manufacturer of Hea...
GlobeNewswire
14:01
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at A...
GlobeNewswire
14:00
Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event
GlobeNewswire
14:00
BriaCell Announces Clinical Supply Agreement with BeiGene for Bria-OTS™ First in Human Study
GlobeNewswire
14:00
Invitation to ScottsMiracle-Gro’s “Meet the Management” Investor Day in Marysville, Ohio
GlobeNewswire
14:00
Marotta Controls Earns Exceptional Small Business Performance Award from Lockheed Martin for the Sec...
Newsfile Corp
14:00
MineHub Appoints New Chief Financial Officer; Announces Timing of Fiscal Fourth Quarter and Annual 2...
Newsfile Corp
14:00
Gaia to Present at Water Tower Research's Inaugural Consumer Products Virtual Investor Conference Ju...
GlobeNewswire
14:00
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility
GlobeNewswire
14:00
Reviva Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
14:00
Tonix Pharmaceuticals Announces Presentation at the 2024 BIO International Convention
GlobeNewswire
14:00
Aquestive Therapeutics to Present Anaphylm™ (epinephrine) Sublingual Film Pharmacokinetic and Pharma...
GlobeNewswire
14:00
Solowin Announces Strategic Partnership with MaiCapital to Expand Virtual Asset Allocation Opportuni...
GlobeNewswire
14:00
Gorilla Technology and SINTRONES Partner to Develop In-Vehicle AI Computing Capabilities
GlobeNewswire
14:00
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página